原发性肝癌切除术后的抗复发治疗被引量：6

在线阅读下载PDF

导出

摘要原发性肝癌（简称肝癌）主要指肝细胞癌（hepa-tocellular carcinoma,HCC）,是居我国第二位的肿瘤死亡原因。目前肝切除术及肝移植术仍是可治愈肝癌的唯一手段。但是,限于供体来源及经济条件,肝移植的应用范围小，肝切除术仍是目前肝癌治疗中最实用、最有效的方法。然而肝癌切除术后的疗效仍不令人满意，术后高复发及转移率是主要影响因素。

作者阎振林李俊沈锋

机构地区第二军医大学附属东方肝胆外科医院

出处《肝胆胰外科杂志》 CAS 2009年第4期253-256,共4页 Journal of Hepatopancreatobiliary Surgery

关键词肝肿瘤外科手术复发治疗

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献9

1Zheng-GangRen Zhi-YingLin Jing-LinXia Sheng-LongYe Zeng-ChenMa Qing-HaiYe Lun-XiuQin Zhi-QuanWu JiaFan Zhao-YouTang.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor:A retrospective control study[J].World Journal of Gastroenterology,2004,10(19):2791-2794. 被引量：83
2沈锋,王皓,谢天培,施乐华,钱卫珠,刘新垣,吴孟超,郭亚军.肝癌特异性细胞毒 T 淋巴细胞的实验及临床研究[J].中华外科杂志,1997,35(2):95-99. 被引量：13
3Jun Wen, Wen-Lv Shen and Shao-Hua Yang Department of Surgery, Second Hospital of Shantou University of Medical College, Shantou 515041 , China.Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):224-227. 被引量：4
4Soo Cheol Jeong,Hiroshi Aikata,Yoshio Katamura,Takahiro Azakami,Tomokazu Kawaoka,Hiromi Saneto,Kiminori Uka,Nami Mori,Shintaro Takaki,Hideaki Kodama,Koji Waki,Michio Imamura,Hiroo Shirakawa,Yoshiiku Kawakami,Shoichi Takahashi,Kazuaki Chayama.Effects of a 24-week course of interferon-αtherapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(40):5343-5350. 被引量：3
5Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
6程红岩,徐雯,徐爱民,陈栋,杨业发,贾雨辰.肝动脉插管化疗栓塞在预防肝癌术后复发中的应用价值[J].中华肿瘤杂志,2005,27(10):626-628. 被引量：30
7Soocheol Jeong,Hiroshi Aikata,Yoshio Katamura,Takahiro Azakami,Tomokazu Kawaoka,Hiromi Saneto,Kiminori Uka,Nami Mori,Shintaro Takaki,Hideaki Kodama,Koji Waki,Michio Imamura,Hiroo Shirakawa,Yoshiiku Kawakami,Shoichi Takahashi,Kazuaki Chayama.Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(39):5188-5195. 被引量：2
8潘烨,郑起,艾开兴,闫钧,薛琼.α干扰素和卡培他滨对肝癌根治性切除术后转移复发抑制作用的实验研究[J].肿瘤,2005,25(5):439-441. 被引量：3
9奚韬,闫振林,王葵,李俊,夏勇,沈锋,吴孟超.术后经导管动脉化疗栓塞对不同病理特征肝癌的抗复发作用[J].中华外科杂志,2007,45(9):587-590. 被引量：23

二级参考文献146

1Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Fudan University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量：80
2Zhao-You Tang,Xin-Da Zhou, Zeng-Chen Ma, Zhi-Quan Wu, Jia Fan, Lun-Xiu Qin and Yao Yu Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032 , China.Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):495-498. 被引量：18
3Li Chen, Yong Liu, Guo-Gang Li, Si-Feng Tao, Yuan Xu and Hua Tian Hangzhou, China : Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009 , China.Quality of life in patients with liver cancer after operation:a 2-year follow-up study[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):530-533. 被引量：9
4Deng-Fu Yao, Zhi-Zhen Dong, Deng-Bing Yao, Xin-Hua Wu, Wei Wu, Li-Wei Qiu, Hong-Mei Wang and Xian-Yong Meng Nantong, China Research Center of Clinical Molecular Biology, Affilia- ted Hospital of Nantong University, Nantong 226001 , China ,Insti- tute of Neuroscicnces, Nantong University, Nantong 226001 , China.Abnormal expression of hepatoma- derived γ-glutamyltransferase subtyping and its early alteration for carcinogenesis of hepatocytes[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):564-570. 被引量：17
5Zheng-GangRen Zhi-YingLin Jing-LinXia Sheng-LongYe Zeng-ChenMa Qing-HaiYe Lun-XiuQin Zhi-QuanWu JiaFan Zhao-YouTang.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor:A retrospective control study[J].World Journal of Gastroenterology,2004,10(19):2791-2794. 被引量：83
6Yong-SongGuan LongSun Xiang-PingZhou XiaoLi Xiao-HuaZheng.Hepatocellular carcinoma treated with interventional procedures:CT and MRI follow-up[J].World Journal of Gastroenterology,2004,10(24):3543-3548. 被引量：31
7Hubert E Blum.Hepatocellular carcinoma: Therapy and prevention[J].World Journal of Gastroenterology,2005,11(47):7391-7400. 被引量：28
8[1]Tsukuma H,Hiyama T,Tanaka S,Nakao M,Yabuuchi T,Kitamura T,Nakanishi K,Fujimoto I,Inoue A,Yamazaki H.Risk factors for hepatocellular carcinoma among patients with chronic liver disease.N Engl J Med 1993; 328:1797-1801
9[2]Takano S,Yokosuka O,Imazeki F,Tagawa M,Omata M.Incidence of hepatocellular carcinoma in chronic hepatitis B and C:a prospective study of 251 patients.Hepatology 1995; 21:650-655
10[3]Shiratori Y,Shiina S,Imamura M,Kato N,Kanai F,Okudaira T,Teratani T,Tohgo G,Toda N,Ohashi M.Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan.Hepatology 1995; 22:1027-1033

共引文献143

1Tianfu Wen,Chen Jin,Antonio Facciorusso,Matteo Donadon,Ho-Seong Han,Yilei Mao,Chaoliu Dai,Shuqun Cheng,Bixiang Zhang,Baogang Peng,Shunda Du,Changjun Jia,Feng Xu,Jie Shi,Juxian Sun,Peng Zhu,Satoshi Nara,JMichael Millis,Qiu Li,Weixia Chen,Wusheng Lu,Hong Tang,Lvnan Yan,Yong Zeng,Bo Li,Jiayin Yang,Wentao Wang,Hong Wu,Mingqing Xu,Zheyu Chen,Changli Lu,Chuan Li,Wei Peng,Xiaoyun Zhang.Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J].Hepatobiliary Surgery and Nutrition,2018,7(5):353-371. 被引量：45
2Wan-Yee Lau,Eric C.H.Lai,Stephanie H.Y.Lau.The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma:a systematic review[J].Hepatobiliary & Pancreatic Diseases International,2009,8(2):124-133. 被引量：24
3Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
4华赟鹏,彭宝岗.预防原发性肝癌术后复发的策略研究[J].消化肿瘤杂志（电子版）,2011,3(2):70-73. 被引量：3
5WU Mengchao Eastem Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.Clinical and Experimental Research of Primary Liver Cancer in China[J].The Chinese-German Journal of Clinical Oncology,2002,1(1):1-4. 被引量：10
6王知力,董宝玮.免疫细胞在恶性肿瘤免疫治疗中应用的研究[J].医学综述,2004,10(12):705-707. 被引量：1
7吴孟超,吴东.原发性肝癌的外科治疗进展[J].临床外科杂志,2005,13(1):4-7. 被引量：24
8冯敢生,吴汉平.介入治疗在预防和治疗肝癌术后复发中的作用[J].临床外科杂志,2005,13(3):139-140. 被引量：2
9李梅,姜愚.肝细胞癌根治术后辅助治疗进展[J].华西医学,2005,20(4):811-812.
10沈锋,吴孟超.肝癌切除术后的抗复发治疗[J].中华医学杂志,2005,85(41):2886-2888. 被引量：26

同被引文献43

1鲁海珍,刘尚梅,赵晓航.肝细胞肝癌复发转移相关因子[J].国际肿瘤学杂志,2006,33(8):612-615. 被引量：3
2Bing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, Zhao-You Tang, Ming-Shan Chen, Jin-Qing Li, An-Min Liang, Qin-Guo Mo, Hui-Shan Lu, Chao-Liu Dai, Lu-Nan Yan, Zhi-Jian Yu, Rong-Sheng Rao, Le-Qun Li, Zhi-Xiong Su, Zhuang-Wei Fang Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China,Tumor Hospital, Zhongshan University, Guangzhou 510000, China Tumor Hospital, Guangxi Medical Universi- ty, Nanning 530000, China,Xiehe Hospital, Fujian Medical University, Fuzhou 350000, China,Second Hos- pital, Chinese Medical University, Shenyang 110000, China ,Huaxi Hospital, Sichuan University, Chengdu 610041, China ,Hospital Affiliated to Nantong Medical University, Nantong 226000 , China,Second Hospital, Jiangxi Medical University, Nanchang 330000 , China ,First Hospital Affiliated to Guangxi Medical University, Nanning 530000 , China ,People’s Hospital of Hainan Province, Haikou 570000, China.Changed clinical aspects of primary liver cancer in China during the past 30 years[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):194-198. 被引量：20
3沈理,陈敏华,严昆,杨薇,高文,廖盛日,杨仁杰.探讨经皮射频消融联合肝动脉化学栓塞治疗大肝癌的临床应用效果[J].中华超声影像学杂志,2004,13(8):577-580. 被引量：10
4谢正兰,袁爱力,刘思德.经导管肝动脉化学栓塞治疗中晚期原发性肝癌268例疗效分析[J].现代消化病及内镜杂志,1997,2(4):354-354. 被引量：1
5罗祥基,陈汉,吴孟超,姜小清,曲增强,胡雷.原发性肝癌术后肝内复发与肝外转移再手术切除疗效分析[J].中国肿瘤,2005,14(3):158-160. 被引量：17
6高宗恩,任晓萍,庞闽厦,孙鹏.肝癌的微血管生成及其在介入治疗中的意义[J].介入放射学杂志,2005,14(3):324-327. 被引量：4
7黄耿文,杨连粤,鲁伟群.老年人肝癌肝切除术后预后分析[J].中华老年医学杂志,2005,24(8):577-579. 被引量：6
8马亦龙,纪昌学.经皮穿脾选择性门静脉栓塞术在中晚期肝癌综合治疗中的应用[J].中国介入影像与治疗学,2005,2(5):345-347. 被引量：5
9程红岩,徐雯,徐爱民,陈栋,杨业发,贾雨辰.肝动脉插管化疗栓塞在预防肝癌术后复发中的应用价值[J].中华肿瘤杂志,2005,27(10):626-628. 被引量：30
10李德辉,孙备.肝细胞癌肝内转移与多中心发生的研究进展[J].国际外科学杂志,2006,33(1):28-31. 被引量：8

引证文献6

1张以滔,王庆军.肝动脉化学栓塞联合手术切除综合治疗大肝癌的临床疗效(附63例临床分析)[J].实用临床医药杂志,2010,14(4):52-53. 被引量：4
2刘勇,赵晋明.原发性肝癌术后复发再治疗临床观察[J].中华实用诊断与治疗杂志,2011,25(5):502-504. 被引量：14
3张乐,李响,牟楠楠,张诚华.老年患者原发性肝细胞癌肝切除术后疗效分析[J].肝胆胰外科杂志,2011,23(3):212-214. 被引量：2
4刘佳,董凤齐.Orem自理模式在肝癌患者术后恢复期的应用[J].天津护理,2012,20(2):78-79. 被引量：5
5孙伟,李忱瑞,周纯武.原发性肝癌术后复发影响因素的临床分析[J].中国医学影像技术,2012,28(6):1148-1151. 被引量：14
6汤玉鹏,黄新辉,赖永平,林承杰,刘腾.原发性肝癌术后复发影响因素的临床分析[J].中国现代药物应用,2016,10(10):103-104. 被引量：2

二级引证文献40

1刘强.原发性肝癌手术治疗联合介入治疗临床疗效观察分析[J].医学信息（医学与计算机应用）,2014,0(2):282-283. 被引量：5
2汤衍斌,林增海,马涛.大肝癌治疗的临床研究现状[J].临床合理用药杂志,2012,5(11):171-172. 被引量：11
3孙崇启,刘雪皎,纪海霞,王丽,牛富强,王晓燕.超声引导下射频消融联合无水乙醇注射治疗危险部位肝癌临床价值[J].中华实用诊断与治疗杂志,2012,26(5):483-484. 被引量：6
4兰涛,苑建磊,王桂华,刘洪军.Bag-1及Bcl-2在肝癌中表达及意义[J].中华实用诊断与治疗杂志,2013,27(3):257-259. 被引量：4
5王军,金焰,李皎.介入栓塞和手术再切除治疗原发性肝癌术后复发患者的疗效[J].中国老年学杂志,2013,33(6):1429-1430. 被引量：21
6冯国全,雷振,徐娜,刘璟怡,魏强.MSCT灌注成像评价恩度抗兔门静脉VX2癌栓新生血管生成的实验研究[J].实用放射学杂志,2013,29(4):651-654. 被引量：4
7袁克文,王湘辉,肖毅,任彦顺,党政.原发性肝癌术后复发现状和影响因素分析[J].检验医学与临床,2013,10(17):2248-2249. 被引量：12
8曾玮,陈平,杨俊涛,刘宏鸣,谢斌,伍强,王伟.原发性肝细胞癌根治性切除术后复发影响因素分析[J].海南医学,2013,24(20):3061-3063.
9刘畅,张宏艳,贾志凌,郑咏秋.褪黑素抑制H22荷瘤小鼠肿瘤生长效果的研究[J].中华实用诊断与治疗杂志,2013,27(11):1056-1058. 被引量：2
10王鹤鹏,武长军,陈百学,刘一范.介入栓塞治疗原发性肝癌异常动脉供血28例临床分析[J].中华实用诊断与治疗杂志,2013,27(11):1128-1129. 被引量：9

1沈锋,吴孟超.肝癌切除术后的抗复发治疗[J].中华医学杂志,2005,85(41):2886-2888. 被引量：26
2徐明,卢明柱,周斌.原发性肝癌术后抗复发治疗[J].中国基层医药,2012,19(22):3383-3384. 被引量：1
3王肇炎.小细胞肺癌化疗的作用与进展[J].海南医学,1999,10(6):118-119. 被引量：1
4明林.患癌后如何预防和减少复发?[J].祝您健康,1995,0(6):47-47.
5史英红.肝细胞癌的生物学行为与相关抑癌基因关系的研究进展[J].医学影像学杂志,2002,12(5):401-403.
6袁萍,黎前明,罗华,文进,梁伯衡,魏莉.肝细胞癌手术患者的人口学和病毒学及临床特征研究[J].肿瘤防治杂志,2005,12(9):651-654. 被引量：1
7段小飞,张水军.肝细胞癌微血管侵犯诊治[J].中华肝脏外科手术学电子杂志,2017,6(2):150-152. 被引量：3
8胡献祥,王伯胤,赵振华,杨建峰.氢质子磁共振波谱在诊断肝脏肿瘤性病变中的应用[J].实用放射学杂志,2014,30(1):79-82. 被引量：3
9金桂龙,丁之玮,贾菊萍.胃癌术后复发转移的超声检查[J].中国肿瘤临床与康复,2005,12(6):532-534. 被引量：1
10陈铁汉,孟丹石.中西医结合治疗恶性淋巴瘤44例临床观察[J].湖南中医杂志,2001,17(5):8-9. 被引量：3

肝胆胰外科杂志

2009年第4期

浏览历史

内容加载中请稍等...

原发性肝癌切除术后的抗复发治疗被引量：6

参考文献9

二级参考文献146

共引文献143

同被引文献43

引证文献6

二级引证文献40

相关作者

相关机构

相关主题

浏览历史

原发性肝癌切除术后的抗复发治疗 被引量：6

参考文献9

二级参考文献146

共引文献143

同被引文献43

引证文献6

二级引证文献40

相关作者

相关机构

相关主题

浏览历史

原发性肝癌切除术后的抗复发治疗被引量：6